Treating Drug-Resistant Tuberculosis

Topic Overview

People infected with tuberculosis (TB) bacteria that are antibiotic-resistant have what is called drug-resistant tuberculosis. There are different types of drug-resistant TB.

  • Mono-resistant TB happens when the bacteria don't respond to one first-line drug.
  • Multidrug-resistant TB happens when the bacteria don't respond to at least the two strongest TB drugs (isoniazid and rifampin).
  • Poly-resistant TB happens when the bacteria don't respond to more than one first line drug other than isoniazid and rifampin.
  • Extensively drug-resistant TB happens when the bacteria are resistant to isoniazid, rifampin, and several other medicines used to treat TB. This is rare.

People with drug-resistant tuberculosis need special treatment programs. Treatment usually involves several medicines.

  • The choice of medicines depends on the results of sensitivity testing.
  • It is very important to take every dose of medicine. So directly observed therapy (DOT) usually is done. During DOT, a health professional watches you take every dose of medicine.
  • Treatment is continued until TB bacteria can no longer be found in two sputum samples taken a month apart. This may take 18 months or longer in people with multidrug-resistant TB (MDR-TB).

Some TB bacteria have become resistant to all of the antibiotics that are commonly used to treat TB. This is sometimes called totally resistant tuberculosis (TDR-TB).footnote 1 A TB infection of this type is very difficult to treat.

Related Information

References

Citations

  1. Cegielski P, et al. (2012). Challenges and controversies in defining totally drug-resistant tuberculosis. Emerging Infectious Diseases [Internet], November. Available online: http://wwwnc.cdc.gov/eid/article/18/11/12-0526_article.htm.

Credits

ByHealthwise Staff
Primary Medical Reviewer E. Gregory Thompson, MD - Internal Medicine
Adam Husney, MD - Family Medicine
Specialist Medical Reviewer R. Steven Tharratt, MD, MPVM, FACP, FCCP - Pulmonology, Critical Care Medicine, Medical Toxicology
W. David Colby IV, MSc, MD, FRCPC - Infectious Disease

Current as ofNovember 22, 2017

 

PeaceHealth endeavors to provide comprehensive health care information, however some topics in this database describe services and procedures not offered by our providers or within our facilities because they do not comply with, nor are they condoned by, the ethics policies of our organization.